Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIRACLE: MHT in Postmenopausal Women with CSVD and MCI
NCT05982470Phase 2Unknown
- Sponsor
- Beijing Tiantan Hospital
- Start
- Aug 2023
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of estradiol topical in Cerebral Small Vessel Disease (CSVD), Mild Cognitive Impairment (MCI) and menopause (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Montreal Cognitive Assessment at 1 year. Status: unknown.
02
Drugs
estradiol topical
03
Conditions
Cerebral Small Vessel Disease (CSVD)Mild Cognitive Impairment (MCI)menopause
Beyond the preview
Go deeper on NCT05982470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05982470.